secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edesa Biotech, Inc. (EDSA)
CIK:        0001540159
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001171843-25-003495
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edesa Biotech shareholders approve 1.725M share increase to 2019 equity plan
----------------------------------------------------------------------------

- Shareholders approved amendment to 2019 Equity Incentive Compensation Plan increasing share reserve by 1,725,000 shares.
- Fungible share pool provisions removed; incentive stock option limit raised from 171,429 to 300,000 shares.
- All seven director nominees elected: Chypyha, Liu, MacDonald, Marshall, Nijhawan, Olson, Sistilli.
- Advisory vote on executive compensation approved with 2,215,325 for, 178,016 against.
- MNP LLP appointed as independent auditor for fiscal year ending September 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/0001171843-25-003495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1540159/000117184325003495/f8k_052825.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer